ISOVAC has designed, developed, commercialized, and currently manufactures products that provide Chemical / Biological / Radiological (CBR) isolation, containment and protection of personnel, casualties, remains, equipment, and transport assets. These products are designed to mitigate the risks and adverse effects of CBR warfare and terrorist attacks, viral outbreaks (e.g., COVID-19, H5N1, SARS, Ebola, etc.), industrial accidents, and natural disasters. ISOVAC's primary markets include all branches of the U.S. Department of Defense as well as those of NATO (North Atlantic Treaty Organization) countries. Major non-military U. S. markets include the Department of Homeland Security (DHS), the Federal Emergency Management Agency (FEMA), and their state, regional, and municipal counterparts. Additional and more dispersed markets include both domestic and international commercial users such as hospitals, local emergency first response units, and fire departments.